BSE filing, NSE: CSURGSU. Summary written from the filing by ALFA Finder's alert engine.
Centenial Surgical Suture Ltd: key numbers
- Share price
- ₹71.25
- Market cap
- ₹25.99 Cr
- Revenue (annual)
- ₹53.84 Cr
- Net profit (annual)
- ₹-2.20 Cr
- P/E (TTM)
- -18.0×Sector 52.0×
- Promoter holding
- 46.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Centenial Surgical Suture Ltd
All →Centenial Surgical Suture Other Announcement
Centenial Surgical Suture Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI listing regulations.
Centenial Surgical Suture Price Movement Clarification
Centenial Surgical Sute reports abnormal share-price movement unsupported by any corporate news and requests BSE/SEBI investigation into suspected manipulative trades. The company states no material announcement explains the unusual price action.
Centenial Surgical Suture Management Change
Anuradha Kashikar has resigned from her position as Executive Director and Key Managerial Personnel (KMP) of Centenial Surgical Suture Ltd, effective October 5, 2026.
Centenial Surgical Suture Annual General Meeting
Centenial Surgical Suture Ltd announced results for its Annual General Meeting held on September 28, 2026. All three resolutions were passed with the requisite majority.
Centenial Surgical Suture Management Change
Centenial Surgical Suture Ltd has appointed Ms. Sapna Mhatre as Chief Financial Officer, succeeding Ms. Anuradha Kashikar, who resigned from the position effective August 14, 2026.
Centenial Surgical Suture Annual Report
Centenial Surgical Suture Ltd has filed its 31st Annual Report for the financial year 2025-2026 as per SEBI (LODR) Regulations.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.